VEGFA and head and neck squamous cell carcinoma: Yang et al. demonstrated that melittin treatment inhibited the growth of head and neck squamous-cell carcinoma (CNE-2 cell line), induced apoptosis in these cells, and reduced the expression of HIF-1α (hypoxia-inducible factor 1α) and VEGF (vascular endothelial growth factor) [82].